Finance

Regencell Bioscience Holdings, a Hong Kong-based company dabbling in traditional Chinese medicine (TCM), has recently taken the stock market by storm, boasting an astronomical leap in share prices that can only be described as speculative mania. With no revenue to speak of and a track record that invites skepticism, the company’s surge—peaking at over 58,000%
0 Comments
China’s economy has recently witnessed an uptick in retail sales growth, with May’s figures rising by an impressive 6.4% compared to the same month last year. For many, this spike might seem like a sign of recovery in the world’s second-largest economy, especially considering the dismal backdrop of ongoing deflation and sluggish growth. But is
0 Comments
Walmart’s recent venture into the financial services sector exemplifies a pivotal shift in strategy that must be examined closely. With its majority-owned fintech startup, OnePay, the retail giant is not only embracing the financial landscape but also aiming to disrupt it. The launch of two new credit cards in partnership with Synchrony marks a significant
0 Comments
In today’s rapidly evolving technological landscape, rare earth elements (REEs) serve as the backbone of many high-tech industries, including automotive, defense, and consumer electronics. As the world becomes increasingly reliant on these precious resources, the significance of their supply chain cannot be overstated. Unfortunately, this dependency has delivered a stunning blow to modern industry as
0 Comments
The discourse surrounding U.S.-China rivalry often revolves around artificial intelligence, overshadowing an equally significant race: biotechnology. Emerging reports reveal that China is not merely advancing; it is poised to potentially eclipse the United States in this critical sector. The Harvard Belfer Center for Science and International Affairs has highlighted that of the five key technology
0 Comments